JPS6330891B2 - - Google Patents
Info
- Publication number
- JPS6330891B2 JPS6330891B2 JP51122247A JP12224776A JPS6330891B2 JP S6330891 B2 JPS6330891 B2 JP S6330891B2 JP 51122247 A JP51122247 A JP 51122247A JP 12224776 A JP12224776 A JP 12224776A JP S6330891 B2 JPS6330891 B2 JP S6330891B2
- Authority
- JP
- Japan
- Prior art keywords
- enteric
- granules
- coated
- ingredients
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008187 granular material Substances 0.000 claims description 26
- 239000004615 ingredient Substances 0.000 claims description 16
- 210000002784 stomach Anatomy 0.000 claims description 13
- 239000007931 coated granule Substances 0.000 claims description 12
- 210000000936 intestine Anatomy 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 102000038379 digestive enzymes Human genes 0.000 claims description 7
- 108091007734 digestive enzymes Proteins 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 description 29
- 238000000034 method Methods 0.000 description 22
- 238000000576 coating method Methods 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 10
- 239000002775 capsule Substances 0.000 description 8
- 108010019160 Pancreatin Proteins 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940055695 pancreatin Drugs 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007940 sugar coated tablet Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000009507 drug disintegration testing Methods 0.000 description 1
- 238000007610 electrostatic coating method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12224776A JPS5347513A (en) | 1976-10-14 | 1976-10-14 | Preparation of enzymatic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12224776A JPS5347513A (en) | 1976-10-14 | 1976-10-14 | Preparation of enzymatic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5347513A JPS5347513A (en) | 1978-04-28 |
| JPS6330891B2 true JPS6330891B2 (cg-RX-API-DMAC10.html) | 1988-06-21 |
Family
ID=14831226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12224776A Granted JPS5347513A (en) | 1976-10-14 | 1976-10-14 | Preparation of enzymatic agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5347513A (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8104293A (nl) * | 1981-09-17 | 1983-04-18 | Ihc Holland Nv | Werkwijze voor het opzuigen van grond of slib met een sleepzuiger alsmede sleepzuiger voor het toepassen van de werkwijze. |
| JPS6248618A (ja) * | 1985-08-27 | 1987-03-03 | Zeria Shinyaku Kogyo Kk | 徐放性製剤およびその製造法 |
| ATE419841T1 (de) * | 2003-09-03 | 2009-01-15 | Pharmaton Sa | Kapseln enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen |
-
1976
- 1976-10-14 JP JP12224776A patent/JPS5347513A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5347513A (en) | 1978-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2433186C (en) | Delayed release pharmaceutical formulations | |
| US5540945A (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
| CA2746855C (en) | Extended-release pharmaceutical formulations | |
| AU2001292086A1 (en) | Delayed release pharmaceutical formulations | |
| NZ201008A (en) | Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient | |
| CS244909B2 (en) | Production method of retarded form of bromohexine | |
| JPH11171775A (ja) | テオフィリン徐放性錠剤 | |
| JP2002326927A (ja) | 塩酸メトホルミン含有速放性錠剤 | |
| WO1999053905A1 (fr) | Comprimes a liberation prolongee a unites multiples | |
| JPS6248618A (ja) | 徐放性製剤およびその製造法 | |
| CA2032475C (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
| US20010001658A1 (en) | Granule modulating hydrogel system | |
| US5234691A (en) | Sustained-release prepararation of basic medical agent hydrochloride | |
| JP2000128779A (ja) | 薬物放出制御型製剤 | |
| KR20010031952A (ko) | 카르베디롤을 위한 신규 경구 투여형 | |
| US4863741A (en) | Tablet composition for drug combinations | |
| JP2002068964A (ja) | 経口用徐放錠 | |
| WO2014063596A1 (zh) | 一种治疗糖尿病的口服制剂 | |
| EP0196002B1 (en) | Tablet composition for drug combinations | |
| JPH1053524A (ja) | イブジラストの徐放化経口錠剤およびその製造方法 | |
| JP2001139469A (ja) | 新しい徐放性薬剤複合体 | |
| JPH0253721A (ja) | 被覆顆粒を含む錠剤 | |
| JP2003104892A (ja) | イトラコナゾール経口用固形製剤 | |
| WO2004024138A1 (ja) | ジオクチルソジウムスルホサクシネート配合固形製剤 | |
| US20040228918A1 (en) | Granule modulating hydrogel system |